tirzepatide glp 1 and gip Understand GLP-1/GIP Dual Agonist Its Effect on Current Weight Loss Therapy Tirzepatide: A Double Approach to

Emerging research suggests these medications may have complementary roles, with combination approaches being explored to improve both metabolic and reproductive outcomes

doi:10.1007/s40264-023-01392-3 125

Patients with established cardiovascular disease or multiple risk factors may benefit from this combination, though with important caveats

Glucagon promotes fat oxidation specifically, potentially sparing muscle tissue to a greater degree

Eating slowly and stopping when comfortably satisfiedrather than overly fullcan prevent uncomfortable gastrointestinal symptoms

These two medications, although similar in function, differ significantly in their mechanism of action and dosing protocols , which may affect how the body responds to treatment